📰 Diffusion Pharmaceuticals News
Page 2 - Diffusion Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Diffusion Pharmaceuticals. Real-time updates on events, politics, business and more.
August 17, 2023
By Ben Glickman Shares of CervoMed nearly doubled Thursday after beginning trading under a new ticker following a merger. The stock was up 98% to $13.10 in...
August 16, 2023
/PRNewswire/ -- CervoMed Inc. (formerly known as Diffusion Pharmaceuticals Inc.) (NASDAQ: CRVO), now a clinical-stage company focused on developing treatments...
August 14, 2023
/PRNewswire/ -- EIP Pharma Inc. ("EIP Pharma" or the "Company"), a privately held clinical-stage company focused on developing treatments for neurodegenerative...
August 3, 2023
/PRNewswire/ -- EIP Pharma Inc., a clinical stage company focused on developing treatments for neurodegenerative diseases, today announced that the Companys...
August 3, 2023
EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference BOSTON, MA - August 3, 2023 - EIP Pharma Inc., a clinical stage company focused on developing treatments...
August 2, 2023
SHAREHOLDER ALERT: Weiss Law Reminds PACW, DFFN, and OLO Shareholders ...
July 28, 2023
StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a research note released on Monday. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance Shares of NASDAQ DFFN opened at $3.13 on Monday. The firm has a market capitalization of $6.39 million, a price-to-earnings ratio of -0.41 […]
July 21, 2023
SHAREHOLDER ALERT: Weiss Law Reminds GHL, OLO, and DFFN Shareholders ...
July 19, 2023
StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a research note issued to investors on Sunday. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance Shares of NASDAQ:DFFN opened at $3.05 on Friday. The business’s 50 day simple moving average is $3.58 and its two-hundred day […]
July 18, 2023
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Free Report) was the target of a large decline in short interest in the month of June. As of June 30th, there was short interest totalling 1,400 shares, a decline of 71.4% from the June 15th total of 4,900 shares. Based on an average daily trading volume, of 8,200 […]